In a bid to rework the controversial relationship between drugmakers and patient charities, Regeneron Pharmaceuticals has announced a new program in which it will match up to $200 million in ...

In a bid to rework the controversial relationship between drugmakers and patient charities, Regeneron Pharmaceuticals has announced a new program in which it will match up to $200 million in ...

The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene therapy ...

Regeneron's donations to independent charity foundations help elderly patients access medicines that are prescribed by their physicians." EYLEA® (aflibercept) ...

In 2019, the charity that Regeneron used to operate its patient assistance program, the Chronic Disease Fund, paid $2 million to resolve allegations that it had served as a conduit to companies ...

The U.S. government filed a lawsuit against Regeneron Pharmaceuticals June 24 alleging the Tarrytown, N.Y.-based drugmaker paid kickbacks to a patient assistance charity to cover Medicare copays ...

EAST GREENBUSH — Drug maker Regeneron, which employs 3,000 at its East Greenbush manufacturing plant, funneled tens of millions of dollars to a medical-assistance charity as part of a Medicare ...

Regeneron in a statement said it would vigorously defend itself. “We do not believe there is any merit to the complaint,” the company said. Its stock price midday Wednesday was $604.62, down 3 ...

Regeneron took a tough stance against the lawsuit—and picked a bone with its timing. It’s “unfortunate that the government chose to bring these baseless allegations related to our 2013 and ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) said that there is no merit to the civil complaint filed by the U.S. Attorney for the District of Massachusetts.

Regeneron (NASDAQ:REGN) Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex landscape of challenges and opportunities in ...